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Abstract
Transplantation of bone marrow mesenchymal stem cells (BM-MSCs) has been shown to ameliorate
the injured central nervous system (CNS). Although these effects were initially attributed to the
putative differentiation of MSCs towards the neural lineage, it is now known that most of them
are mediated by the secretome. Up to now most in vitro reports have dealt with the effects of
the secretome on neural stem cells and their differentiation. Consequently, there is a lack of
information regarding the role of the secretome on the viability and survival of pre-existent matured
differentiated cell populations. Moreover, it is also not known how the time points of conditioned
media (CM) collection affect such parameters. In the present study, primary cultures of hippocampal
neurons and glial cells were incubated with CM obtained fromMSCs. To determine how the temporal
profiles of CM collection impact on post-natal neurons and glial cells, we collected MSCs CM at 24,
48, 72 and 96 h of conditioning. MTS test revealed that for the hippocampal cultures the incubation
with CM increased cell viability for all time points, with significant increases in the percentage
of neurons in culture incubated with CM 24 h. For glial cells only the later time point of CM
collection (96 h) increased cell viability. Fluorescence microscopy observations also revealed that
CM 48 h and 72 h increased astrocytes percentages, while CM 24 h decreased microglial cell and
oligodendrocytes values. These results revealed that post-natal neuronal and glial cells respond
differently to MSCs CM; moreover, there are specific temporal variations in the composition of the
CM of MSCs collected at different time points that trigger different effects on mature neurons and
the distinct glial cell populations (astrocytes, oligodendrocytes and microglial cells). Copyright 
2011 John Wiley & Sons, Ltd.
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1. Introduction
Mounting evidence indicates the possible use of Mes-
enchymal Stem Cells (MSCs) as therapeutical agents
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for different CNS-related problems. Most studies have
focused on MSCs’ impact on phenomena such as neural
cell proliferation and differentiation. For instance, Munoz
et al. (2005) revealed that the implantation of human
MSCs in the mousee dentate gyrus (DG) stimulated prolif-
eration, migration and differentiation of the endogenous
neural stem cells populations. Other authors have also
revealed that the transplantation of MSCs into differ-
ent animal injury/disease models, such as stroke (Li et al.,
2005; Li and Chopp, 2009), spinal cord injury (SCI) (Deng
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et al., 2006; Urdzikova´ et al., 2006) or Parkinson’s Disease
(PD) (Chao et al., 2009; Park et al., 2008; Shintani et al.,
2007) led to a significant reduction in the volume of dam-
aged tissues, increased cognitive capabilities upon injury
or a significant improvement in motor skills. While these
effects can be ascribed to the proliferation/differentiation
of local neural stem cell (NSC) populations, there is also
a strong possibility that they are related to the trophic
influence on the survival and protection of mature res-
ident glial and neuronal cell populations. Reports such
as those presented by Bai et al. (2007), Crigler et al.
(2006) and Wislet-Gendebien et al. (2004) clearly indi-
cate that the secretome of MSCs possesses regulatory
factors able to stimulate neuronal, oligodendrogenic and
astrocytic survival/protection and differentiation. Never-
theless, although there has been an increasing body of
literature dealing with effects of the secretome of MSCs
in the CNS, there are still some missing gaps within the
field. For instance, few reports deal with the effects of
the secretome of MSCs on mature cultures of postna-
tal neurons and glial cells, as most in vitro studies have
been performed with NSCs. Moreover, as the secretome
of MSCs might change with time, it is also relevant to
characterize the temporal profile of conditioned media
(CM) collection in terms of cell viability, survival and cell
densities, as subtle changes in the CM might stimulate
some cell populations while inhibiting others. Therefore,
the objectives of the present study were to evaluate the
effects of MSCs conditioned media and the temporal
profile of its collection on the viability and cell densi-
ties of post-natal cultures of hippocampal neurons and
glial cells. The results revealed that the time point of
MSCs CM collection distinctly affects neurons, astrocytes,
oligodendrocytes and microglial cells.
2. Materials and methods
Bone marrow MSCs (BM-MSCs) were acquired from
Lonza (Basel, Switzerland). Upon arrival they were
thawed and expanded according to the company
guidelines. Hippocampal neuron cultures were prepared
from P4 Wistar rats (Lu et al., 2005). Briefly, and
upon dissection, the hippocampi were submitted to
trypsin-based enzymatic digestion followed by mechanical
dissociation. Isolated cells were then plated on coverslips
previously coated with poly-D-lysine (Sigma, USA) at
a density of 40 000 cells/cm2. Cortical glial cells were
isolated from P4 newborn Wistar rats (Salgado et al.,
2009). Upon dissection, the cortices were enzymatically
digested (30 mg/ml DNase, 0.25% trypsin; both from
Sigma), followed by strong mechanical dissociation. Glial
cells were then obtained by centrifuging the resulting cell
suspension at 800 rpm for 2 min and were plated out on
coverslips previously coated with poly-D-lysine at a density
of 40 000 cells/cm2. CM were collected from P5 MSCs.
For this purpose, the cells were plated out at a density of
4000 cells/cm2 and allowed to grow for 3 days. Following
this, the culture medium was renewed and CM collected
24, 48, 72 and 96 h thereafter (cell culture medium was
not renewed or added during this time period). Upon
collection, the CMs were frozen and later thawed on
the day of the experiments. For CM collection, standard
MSCs culture medium was used for experiments with glial
cells, while for experiments with hippocampal neurons,
Neurobasal-A medium (Gibco, USA) supplemented with
kanamycin (0.1 mg/ml; Gibco) was the chosen medium.
Experiments with glial cells and hippocampal neurons
were performed as follows.
Hippocampal neurons. Upon isolation, hippocampal
neurons were plated out at the densities referred to above
and incubated from T0 with the previously collected CM
(n = 3/CM time point) for 7 days (with half of the volume
of CM being renewed at day 4 of culture), after which
cell densities, viability and proliferation were assessed
(see below). Besides kanamycin and glutamax, no further
supplements were added to the MSCs CM. Control
cultures were kept in neurobasal medium supplemented
with kanamycin and glutamax.
Glial cells. Upon isolation, glial cells were allowed
to grow for 5 days. On day 5 the culture medium was
switched to CM (n = 3/CM time point); after incubation
for further 9 days, cell densities and viability were
assessed (see below). Control cultures were kept in
α-MEM supplemented with 1% antibiotics/antimycotics
(Sigma). The different time periods of CM incubation
for neurons and glial cells were mainly related to
their maturation stage. For hippocampal neurons, the
maturation stage is 7 days, while for cortical glial cells it
is 14 days (Lu et al., 2005; Salgado et al., 2009).
Cell viability was assessed by the MTS test. Cell
culture coverslips (n = 3) were placed in culture
medium containing (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2(4-sulfophenyl)-2H tetrazoli-
um) (MTS) in a 5 : 1 ratio and incubated in a humidified
atmosphere at 37 ◦C and 5% CO2. After 3 h of incuba-
tion, 100 µl solution from each sample were transferred
to 96-well plates and the optical density was determined
at 490 nm (n = 3/CM time point ± SD).
Immunocytochemistry was performed according to our
previously described procedures (Salgado et al., 2010).
The following primary and secondary antibodies were
used: mouse anti-rat microtubule-associated protein 2
(MAP-2; Sigma, USA) to detect mature hippocampal
neurons; rabbit anti-rat glial fibrillary acid protein
(GFAP; Dako, Denmark) for astrocytes; mouse anti-CD11b
(BD Biosciences, Pharmigen, USA) for microglial cells;
mouse anti-O4 (R&D Systems, USA) for oligodendrocytes;
Alexa Fluor 594 goat anti-mouse immunoglobulin G
(IgG) and Alexa Fluor 488 rabbit anti-rat IgG. Nuclei
were counterstained with DAPI (Molecular Probes).
Primary antibody was omitted to produce negative
controls. Samples were observed under a Olympus BX-61
fluorescence microscope (Olympus, Germany).
Cell counts were performed by using Cell-P software
(Olympus, Germany). For this purpose, three cover slips
per condition and three representative fields were chosen
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and analysed. In order to normalize the data between the
different sets of cell cultures, the results are presented in
percentages of cells. This was calculated by counting the
cells positive for the above-referred markers and dividing
this value by the total number of cells/field (DAPI-positive
cells). Statistical evaluation was performed using one-
way ANOVA to assess the statistical differences between
different groups. Statistical significance was defined as
p < 0.05 for a 95% confidence interval.
3. Results and discussion
In the present report we aimed to determine how CM
from MSCs collected at different time points affected
the metabolic viability and cell densities in primary
cultures of post-natal (P4) hippocampal neurons and
cortical glial cells. As can be observed in Figure 1A, the
incubation of hippocampal neuronal cultures with MSCs
CM leads to an increase of the metabolic viability; values
from all time points were above control cultures (CM
24 h and CM 72 h, p < 0.05). Analysis of differentiated
neurons (by observing MAP-2 immunostained coverslips)
revealed that CM 24 h triggers the most striking effect
on neuronal densities (Figure 1B, C): with this CM,
approximately 20% (p < 0.05) of MAP-2-positive cells
could be observed, which corresponds to four times more
than those presented in the control condition (p < 0.05).
It should be noted that the low values obtained by the
control were expected, as cultures were kept without
the B27 supplement. In primary cultures of postnatal
cortical glial cells, the results for the metabolic viability
upon incubation with MSCs CM were variable. As can
be observed in Figure 2A, the two initial CM time points
had lower levels of metabolic viability when compared
to control cultures (p < 0.05). This effect was then
inverted with CM 96 h, disclosing a small but statistically
significant increase in glial cell viability (p < 0.05) when
compared to the control. Immunostaining for GFAP
(astrocytes; Figure 2B, E, H), CD11b (microglial cells;
Figure 2C, F, I) and O4 (oligodendrocytes; Figure 2D, G,
J) revealed distinct effects at the subpopulation level.
The most relevant effects for astrocytes were achieved
with MSCs CM 48 h and CM 72 h (p < 0.05). On the
other hand, we observed reduced microglial cells densities
whenever cultures were incubated with MSCs CM 24 h.
Finally, oligodendrocytes densities seem to be negatively
affected by the initial MSCs CM (24 h and 48 h). While the
results obtained with microglial cells were expected, as
it is known the immunomodulatory phenotype of MSCs
on inflammatory cells, including microglial cells (Kim
et al., 2009; Ohtaki et al., 2008; Rossignol et al., 2009;
Zhou et al., 2009), the results obtained for astrocytes
and oligodendrocytes were quite surprising. Previous
Figure 1. Hippocampal neurons incubated with MSCs CM. MTS test (A) revealed that all the CM time points induced higher rates
of metabolic viability when compared to control cultures (CM 24 h and CM 72 h were statistically significantly different from the
control; one-way ANOVA, n = 3, mean ± SD, p < 0.05). For immunocytochemistry (B–D), MAP-2 was used to label hippocampal
neurons in cultures. Cell counts revealed that CM 24 h incubated cultures (B, D) had a higher overall percentage of MAP-2-positive
neurons (statistically significantly different from the control; one-way ANOVA, n = 3, mean ± SD, p < 0.05) when compared to
controls (B, C)
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Figure 2. Glial cell incubation with MSCs CM. Cell metabolic viability (A) seemed to be affected for earlier CM time points (24 h and
48 h; CM 24 h statistically significantly different from the control; one-way ANOVA, n = 3, mean ± SD, p < 0.05). With increasing
CM time point collections, namely CM 96 h (statistically significantly different from the control; one-way ANOVA, n = 3, mean ±
SD, p < 0.05) these effects were inverted. Immunocytochemistry for GFAP (astrocytes; B, E, H), CD11b (microglial cells; C, F, I) and
oligodendrocytes (O4; D, G, J) revealed that the incubation of glial cell cultures with CM 48 h and CM 72 h increased (statistically
significantly different from the control, one-way ANOVA, n = 3, mean ± SD, p < 0.05) the percentage of astrocytes. On the other
hand, CM 24 h induced a decrease in the percentages of microglial cell and oligodendrocytes (statistically significantly different
from the control; one-way ANOVA, n = 3, mean ± SD, p < 0.05)
reports (Bai et al., 2007; Riviera et al., 2006; Wislet-
Gendebien et al., 2004) revealed that NSCs differentiate
into oligodendrocytes to the detriment of astrocytes when
incubated with MSCs CM or maintained in co-cultures
using transwell systems. However, herein we demonstrate
that these distinct effects are dependent on the time of
CM collection; indeed, whereas collection of CM at earlier
time points induce higher densites of astrocytes, later time
points promote a higher survival rate of oligodendrocytes.
The latter observation fits previous studies reporting that
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oligodendrogenic differentiation was only achieved with
longer periods of MSC conditioning (Bai et al., 2007).
Therefore, these results show that the temporal profile of
the CM secretome determines its effects on mature and
differentiated cells.
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